首页> 美国卫生研究院文献>Metabolites >MOTA: Network-Based Multi-Omic Data Integration for Biomarker Discovery
【2h】

MOTA: Network-Based Multi-Omic Data Integration for Biomarker Discovery

机译:MOTA:用于生物标记物发现的基于网络的多组数据集成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The recent advancement of omic technologies provides researchers with the possibility to search for disease-associated biomarkers at the system level. The integrative analysis of data from a large number of molecules involved at various layers of the biological system offers a great opportunity to rank disease biomarker candidates. In this paper, we propose MOTA, a network-based method that uses data acquired at multiple layers to rank candidate disease biomarkers. The networks constructed by MOTA allow users to investigate the biological significance of the top-ranked biomarker candidates. We evaluated the performance of MOTA in ranking disease-associated molecules from three sets of multi-omic data representing three cohorts of hepatocellular carcinoma (HCC) cases and controls with liver cirrhosis. The results demonstrate that MOTA allows the identification of more top-ranked metabolite biomarker candidates that are shared by two different cohorts compared to traditional statistical methods. Moreover, the mRNA candidates top-ranked by MOTA comprise more cancer driver genes compared to those ranked by traditional differential expression methods.
机译:眼科学技术的最新发展为研究人员提供了在系统水平上搜索与疾病相关的生物标记的可能性。对来自涉及生物系统各层的大量分子的数据进行的综合分析提供了对疾病生物标志物候选物进行排名的绝佳机会。在本文中,我们提出了MOTA,这是一种基于网络的方法,它使用在多层获取的数据来对候选疾病生物标记物进行排名。由MOTA构建的网络允许用户调查排名靠前的生物标志物候选物的生物学意义。我们从代表三组肝细胞癌(HCC)病例和肝硬化对照组的三组多组学数据中,评估了MOTA在疾病相关分子排名中的表现。结果表明,与传统的统计方法相比,MOTA可以鉴定出两个不同队列共享的更多顶级代谢物生物标志物候选物。此外,与通过传统差异表达方法排名的那些相比,在MOTA中排名最高的mRNA候选者包含更多的癌症驱动基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号